Samrat Pharmachem Ltd

Wed 2/09/2026,16:1:0 | BSE : SAMRATPH

₹227.00-7.70 (-3.28%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 231.25

Previous Close

₹ 234.70

Volume

1802

Mkt Cap ( ₹ Cr)

₹ 70.14

High

₹ 234.70

Low

₹ 225.00

52 Week High

₹ 333.00

52 Week Low

₹ 190.00

Book Value Per Share

₹ 223.50

Dividend Yield

₹ 0.42

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Samrat Pharmachem Ltd

Your Vote -

Buy

66.67%

Hold

16.67%

Sell

16.67%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Samrat Pharmachem Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Samrat Pharma - Book Closure: Sunday, September 20, 2026 To Tuesday, September 22, 2026 (Both Days Inclusive)

    27 Aug 2026, 8:42PM The Register of Members and Share Transfer books will remain closed from September 20,2026 To September 22, 2026 (both days inclusive)
  • Samrat Pharma - 34Th Annual General Meeting Of Samrat Pharmachem Limited To Be Held On Wednesday, September 23, 2026

    27 Aug 2026, 8:37PM 34th Annual General Meeting of the company will be held on Wednesday, September 23, 2026 at 1:00 PM (IST) through Video Conferencing (VC) / Other Audi
  • Samrat Pharma - Reg. 34 (1) Annual Report.

    27 Aug 2026, 8:04PM 34th Annual Report for the Financial Year 2025-26
  • Samrat Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today

    14 Aug 2026, 8:15PM The Board considered and adopted the unaudited financial results for the quarter ended June 30, 2026
  • Samrat Pharma - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    17 Jul 2026, 3:44PM Appointment of Statutory Auditors for the company from 34th Annual General Meeting to 39th Annual General Meeting
  • Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Jul 2026, 2:59PM Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 2026
  • Samrat Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    13 Jul 2026, 6:50PM As of June 2026, 49.09% is owned by Indian Promoters and 50.91% by Public. <p align=justify> Top five Promoters holding highest number of shares of Sa
  • Samrat Pharma - Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended J

    30 Jun 2026, 3:11PM Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider a

Key fundamentals

Evaluate the intrinsic value of Samrat Pharmachem Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 78.8865 81.7151 73.4517 81.8026 54.3414
Liabilities 78.8865 81.7151 73.4517 81.8026 54.3414
Equity 3.0897 3.0897 3.0897 3.0897 3.0897
Gross Profit -2.1396 10.2415 2.4695 23.9274 24.3433
Net Profit -3.312 7.1122 2.1626 16.6305 17.1849
Cash From Operating Activities 8.8799 -10.0914 9.412 -9.4368 17.7819
NPM(%) -1.14 2.48 0.76 5.35 7.74
Revenue 289.7212 285.8605 281.5812 310.6459 221.8117
Expenses 291.8608 275.619 279.1117 286.7185 197.4684
ROE(%) -4.79 10.29 3.13 24.08 24.88

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Samrat Pharmachem Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 22.05 133.95 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 109.05 0.05 1542.57 488.09 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.55 -0.26 0.00 1013.43 -39.50 0.00
Astec Lifesciences Ltd 572.25 1.05 0.00 522.96 -363.14 0.00

Company Info

Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.

Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.

Parent Organisation

Samrat Pharmachem Ltd.

Founded

16/06/1992

Managing Director

Mr.Lalit Mehta

NSE Symbol

FAQ